Peter Gillgren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter Gillgren has a total of 676 co-authors. Here are the top co-authors by number of shared publications:
David Lindström
Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University, Uppsala, Sweden
6 shared publicationsJohan Hansson
Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
5 shared publications- Rebecka Hultgren
Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm
5 shared publications Anders Wanhainen
Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden
4 shared publications- Anders Wanhainen
Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University, 751 85 Uppsala, Sweden
4 shared publications - Carl-Magnus Wahlgren
Department of Molecular Medicine and Surgery, Vascular Surgery Karolinska Institutet Stockholm Sweden
4 shared publications
Latest Publications
- Open Access
- 15 July 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
Impact of Paclitaxel Coated Devices on Limb Salvage and Target Vessel Revascularisation Rates following Isolated Femoropopliteal or Infrapopliteal Endovascular Revascularisation for Chronic Limb Threatening Ischaemia: Insights from the SWEDEPAD 1 Trial
- 15 July 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
Open AccessImpact of Paclitaxel Coated Devices on Limb Salvage and Target Vessel Revascularisation Rates following Isolated Femoropopliteal or Infrapopliteal Endovascular Revascularisation for Chronic Limb Threatening Ischaemia: Insights from the SWEDEPAD 1 Trial
- Open Access
- 28 November 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (4) , 699-700
The Impact of Intra-operative Angioscopy during Carotid Endarterectomy
- 28 November 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (4) , 699-700
Open AccessThe Impact of Intra-operative Angioscopy during Carotid Endarterectomy
- Open Access
Primary Subclavian Venous Thrombosis - Multidisciplinary Collaboration Improves Early Identification and Frequency of Surgical Intervention
Primary subclavian venous thrombosis (PSVT) is a rare but potentially disabling condition caused by chronic compression of the subclavian vein at the thoracic outlet, typically affecting young individuals. Delayed diagnosis often leads to post-thrombotic syndrome (PTS) due to missed opportunities for early surgical intervention. In Stockholm, Sweden, a regional awareness and referral program initiated in 2013 significantly increased early detection and intervention rates. Between 2013 and 2024, 283 PSVT cases were identified, with incidence rising from 0.6 to 1.5 per 100,000/year, attributed to improved detection. Early surgical intervention rose from 66% to 83%, while PTS cases requiring delayed surgery dropped by 50%. These results underscore the benefit of structured regional programs.
Open AccessPrimary Subclavian Venous Thrombosis - Multidisciplinary Collaboration Improves Early Identification and Frequency of Surgical Intervention
Primary subclavian venous thrombosis (PSVT) is a rare but potentially disabling condition caused by chronic compression of the subclavian vein at the thoracic outlet, typically affecting young individuals. Delayed diagnosis often leads to post-thrombotic syndrome (PTS) due to missed opportunities for early surgical intervention. In Stockholm, Sweden, a regional awareness and referral program initiated in 2013 significantly increased early detection and intervention rates. Between 2013 and 2024, 283 PSVT cases were identified, with incidence rising from 0.6 to 1.5 per 100,000/year, attributed to improved detection. Early surgical intervention rose from 66% to 83%, while PTS cases requiring delayed surgery dropped by 50%. These results underscore the benefit of structured regional programs.
- Open Access
- 24 June 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (3) , 397-406
Semi-Conservative Treatment Versus Radical Surgery in Abdominal Aortic Graft and Endograft Infections
- 24 June 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (3) , 397-406
Open AccessSemi-Conservative Treatment Versus Radical Surgery in Abdominal Aortic Graft and Endograft Infections
- Open Access
- 3 March 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (6) , 778-786
Long Term Mortality Rate in Patients Treated with Carotid Endarterectomy
- 3 March 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (6) , 778-786
Open AccessLong Term Mortality Rate in Patients Treated with Carotid Endarterectomy
- Open Access
- 23 December 2021
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 8 (1) , 119-120
Large symptomatic carotid web in young African-Swedish man
- 23 December 2021
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 8 (1) , 119-120
Open AccessLarge symptomatic carotid web in young African-Swedish man
- Open Access
- 1 September 2021
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 62 (3) , 400-407
Risk Factors for Abdominal Compartment Syndrome After Endovascular Repair for Ruptured Abdominal Aortic Aneurysm: A Case Control Study
- 1 September 2021
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 62 (3) , 400-407
Open AccessRisk Factors for Abdominal Compartment Syndrome After Endovascular Repair for Ruptured Abdominal Aortic Aneurysm: A Case Control Study
- Open Access
The Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden
Background: Cure proportion represents the proportion of patients who experience the same mortality rate as the general population and can be estimated together with the survival of the proportion experiencing excess mortality (the uncured). The aim was to estimate the cure proportions and survival among uncured stage II–III cutaneous melanoma (CM) patients. Methods: 1- and 5-year relative survival ratios, cure proportions and the median survival times of uncured stage II–III CM patients in Sweden (n = 6466) were calculated based on data from the nationwide population-based Swedish Melanoma Register 2005–2013 with a follow-up through 2018. Results: Stages IIB and IIC showed significant differences in standardized cure proportions vs. stage IIA CM (0.80 (95% CI 0.77–0.83) stage IIA; 0.62 (95% CI 0.59–0.66) stage IIB; 0.42 (95% CI 0.37–0.46) for stage IIC). Significant differences in standardized cure proportions were found for stages IIIB and IIIC-D CM vs. stage IIIA (0.76 (95% CI 0.68–0.84) stage IIIA; 0.52 (95% CI 0.45–0.59) stage IIIB; 0.35 (95% CI 0.30–0.39) for stage IIIC–D). Conclusions: The results are emphasizing the poor prognosis with low proportions cured by surgery only for sub-groups of stage II–III CM, specifically within stages IIB–C CM.
Open AccessThe Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden
Background: Cure proportion represents the proportion of patients who experience the same mortality rate as the general population and can be estimated together with the survival of the proportion experiencing excess mortality (the uncured). The aim was to estimate the cure proportions and survival among uncured stage II–III cutaneous melanoma (CM) patients. Methods: 1- and 5-year relative survival ratios, cure proportions and the median survival times of uncured stage II–III CM patients in Sweden (n = 6466) were calculated based on data from the nationwide population-based Swedish Melanoma Register 2005–2013 with a follow-up through 2018. Results: Stages IIB and IIC showed significant differences in standardized cure proportions vs. stage IIA CM (0.80 (95% CI 0.77–0.83) stage IIA; 0.62 (95% CI 0.59–0.66) stage IIB; 0.42 (95% CI 0.37–0.46) for stage IIC). Significant differences in standardized cure proportions were found for stages IIIB and IIIC-D CM vs. stage IIIA (0.76 (95% CI 0.68–0.84) stage IIIA; 0.52 (95% CI 0.45–0.59) stage IIIB; 0.35 (95% CI 0.30–0.39) for stage IIIC–D). Conclusions: The results are emphasizing the poor prognosis with low proportions cured by surgery only for sub-groups of stage II–III CM, specifically within stages IIB–C CM.
- 1 September 2020
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 60 (3) , 409
Pseudoxanthoma Elasticum and Isolated Iliac Artery Occlusion
- 1 September 2020
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 60 (3) , 409
Pseudoxanthoma Elasticum and Isolated Iliac Artery Occlusion
- 1 August 2020
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 73 (8) , 1540-1546
Risk Factors for Complications and Long-Term Outcomes Following Completion Lymph Node Dissection for Cutaneous Melanoma: A Retrospective Cohort Study
- 1 August 2020
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 73 (8) , 1540-1546
Risk Factors for Complications and Long-Term Outcomes Following Completion Lymph Node Dissection for Cutaneous Melanoma: A Retrospective Cohort Study